Vaidya Sane Ayurved Laboratories Ltd
Vaidya Sane Ayurved Laboratories Ltd is engaged in treatment of chronic ailments like cardiac disease, diabetes, hypertension and obesity through innovative therapies primarily developed through Ayurveda.[1]
- Market Cap ₹ 163 Cr.
- Current Price ₹ 155
- High / Low ₹ 249 / 98.0
- Stock P/E 46.6
- Book Value ₹ 34.1
- Dividend Yield 0.00 %
- ROCE 22.6 %
- ROE 15.3 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.57% for last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| 62.30 | 74.61 | 52.01 | 74.24 | |
| 59.20 | 71.70 | 47.54 | 66.90 | |
| Operating Profit | 3.10 | 2.91 | 4.47 | 7.34 |
| OPM % | 4.98% | 3.90% | 8.59% | 9.89% |
| 0.07 | 0.07 | -1.06 | 0.32 | |
| Interest | 0.70 | 1.20 | 0.51 | 0.63 |
| Depreciation | 1.59 | 2.23 | 2.45 | 2.29 |
| Profit before tax | 0.88 | -0.45 | 0.45 | 4.74 |
| Tax % | 44.32% | -24.44% | 15.56% | 27.00% |
| Net Profit | 0.50 | -0.56 | 0.39 | 3.47 |
| EPS in Rs | 111.11 | -124.44 | 86.67 | 3.30 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 91% |
| TTM: | 275% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| 0.05 | 0.05 | 0.05 | 10.51 | |
| Reserves | 8.74 | 8.17 | 9.72 | 25.37 |
| 8.67 | 5.97 | 1.02 | 1.06 | |
| 11.41 | 14.93 | 15.02 | 14.81 | |
| Total Liabilities | 28.87 | 29.12 | 25.81 | 51.75 |
| 15.66 | 15.51 | 17.16 | 17.01 | |
| CWIP | 2.02 | 3.79 | 0.38 | 1.23 |
| Investments | 0.02 | 0.02 | 0.01 | 4.88 |
| 11.17 | 9.80 | 8.26 | 28.63 | |
| Total Assets | 28.87 | 29.12 | 25.81 | 51.75 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| 1.58 | 7.72 | 5.77 | -13.12 | |
| -10.05 | -3.93 | -0.67 | -7.71 | |
| 7.71 | -3.63 | -5.26 | 22.49 | |
| Net Cash Flow | -0.77 | 0.16 | -0.16 | 1.66 |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|
| Debtor Days | 21.38 | 12.23 | 18.53 | 17.50 |
| Inventory Days | 76.92 | 49.49 | 35.00 | 24.82 |
| Days Payable | 137.65 | 138.39 | 146.74 | 122.11 |
| Cash Conversion Cycle | -39.34 | -76.67 | -93.21 | -79.79 |
| Working Capital Days | -7.15 | -26.07 | -46.39 | 56.34 |
| ROCE % | 4.74% | 16.97% | 22.59% |
Clinics Network
As per Jan 2022, the company operates ~274 clinics out of which 52 are company owned and the rest are franchise clinics. It also owns 2 cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur respectively.[1]